Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Prolactinoma 2Hyperprolactinemia 2Prolactin Deficiency, Isolated 1Polycystic Ovary Syndrome 1Pituitary Neoplasms 1

Interventions

Proton Therapy 2Surgical Procedures, Operative 1Radiation Dose Hypofractionation 1Protons 1Nivolumab 1Neurosurgical Procedures 1Ipilimumab 1Dosage Forms 1Deamino Arginine Vasopressin 1Clinical Laboratory Techniques 1Cabergoline 1Blood Specimen Collection 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pituitary Neoplasms × Cabergoline × 1 year × Clear all
NCT07034859 2025-06-24

Cabergoline in the Management of Nonfunctioning Pituitary Adenoma

National Taiwan University Hospital

Phase 4 Enrolling by invitation
30 enrolled
Endocrine

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡